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Abstract	The	MICOS	complex	protein	MicF	has	recently	been	identified	to	play	a	vital	role	in	the	mitochondrial	DNA	inheritance	checkpoint,	a	control	system	that	halts	cell	cycle	progression	in	cells	lacking	mitochondrial	DNA	(mtDNA).	We	show	in	this	report	that	another	member	of	the	complex,	MicA,	also	plays	an	important	role	in	the	mtDNA	inheritance	checkpoint	as	its	deletion	led	to	cell	cycle	progression	in	cells	lacking	mtDNA	(Rho0	cells).	We	observed	that	deletion	of	MicA,	just	like	deletion	of	MicF,	led	to	aggregated	mtDNA	in	addition	to	the	severe	defects	in	the	architecture	of	the	inner	mitochondrial	membrane	observed	in	all	MICOS	deletion	strains.	These	findings	lead	us	to	believe	that	MicA	and	MicF	might	be	involved	in	the	signal	transduction	from	mtDNA	across	the	mitochondrial	membranes	and	that	their	deletion	leads	to	loss	of	contact	sites	between	the	membranes	and	thereby	renders	transduction	across	the	membranes	impossible.	
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1.	Introduction	Severe	neurodegenerative	diseases	like	Alzheimer’s	and	Parkinson’s	disease	are	incurable	and	continue	to	plague	millions	of	people	worldwide	each	day.	At	the	same	time,	metabolic	diseases	like	diabetes	type	II	are	a	continually	growing	global	health	problem.	These	are	a	few	examples	of	diseases	that	have	all	been	linked	to	a	common	source:	mitochondria	[1] [2].			Already	in	1956,	Otto	Warburg	discovered	a	link	between	abnormal	mitochondrial	behavior	and	cancer.	He	found	that	cancer	cells	even	in	presence	of	oxygen	exhibited	high	levels	of	glycolysis	and	low	mitochondrial	respiratory	activity [3].	Observations	have	been	made	that	the	copy	number	of	mitochondrial	DNA	(mtDNA)	is	altered	in	every	cancer	form	studied.	Further	studies	have	shown	that	dysregulation	of	the	mtDNA	checkpoint	alters	its	copy	number,	possibly	suggesting	its	involvement	in	the	Warburg	effect	[4].	Moreover,	mutations	of	the	mtDNA	have	been	shown	to	possibly	lead	to	defects	in	heart	and	skeletal	muscles	in	addition	to	being	involved	in	aging	and	the	age-related	neurodegenerative	diseases	previously	mentioned	[5].		The	mitochondrial	contact	site	and	cristae	organizing	system	(MICOS)	complex,	a	protein	complex	present	in	the	inner	mitochondrial	membrane,	has	been	shown	to	be	vital	for	the	maintenance	of	mtDNA	as	well	as	properly	functioning	respiratory	activity	due	to	its	maintenance	of	the	inner	membrane	architecture	[6] [7].	Interestingly,	studies	carried	out	by	Pallavi	Srivastava	of	the	Pon	lab	showed	that	deletion	of	one	of	the	MICOS	components	led	to	bypass	of	the	mtDNA	inheritance	checkpoint,	indicating	its	role	in	the	signal	transduction	from	the	mtDNA	nucleoids	in	the	mitochondrial	matrix	to	the	cytosol	(Unpublished	data).	Up	to	this	point,	little	is	however	known	about	the	possible	involvement	of	the	remaining	members	of	the	MICOS	complex.		The	goal	of	this	study	is	therefore	to	map	out	the	function	of	the	remaining	components	of	the	MICOS	complex	and	trying	to	determine	their	possible	involvement	in	mediating	signal	transduction	from	the	mitochondrial	matrix	to	the	outer	mitochondrial	membrane,	thereby	elucidating	their	possible	roles	in	the	mtDNA	inheritance	checkpoint.		In	order	to	do	so,	yeast	of	the	species	Saccharomyces	cerevisiae,	also	known	as	baker’s	yeast,	was	used	as	a	model	organism.	Particularly,	its	short	replicative	lifespan	allows	us	to	more	efficiently	evaluate	growth	rate	and	cell	cycle	progression.	Due	to	the	nature	of	the	project,	where	numerous	transformations	are	required,	yeast	is	an	excellent	model	organism,	since	it	is	easily	genetically	manipulated.	Importantly,	it	also	has	many	similarities	to	human	cells	and	higher	eukaryotes	in	terms	of	cellular	organization.		 	
2.	Theoretical	background	
Mitochondria	The	mitochondrion	was	likely	first	discovered	in	the	1840s,	when	the	first	intracellular	constituents	were	seen.	The	ability	to	carry	out	oxidative	phosphorylation	makes	mitochondrion	the	powerhouse	of	the	eukaryotic	cell.	Although	being	what	it	is	most	commonly	known	for,	providing	energy	is	far	from	its	only	function.	The	mitochondrion	has	also	been	shown	to	play	a	crucial	role	in	apoptosis	[8]	and	is	responsible	for	biosynthesis	of	vital	cellular	components	such	as	fatty	acids	and	steroid	hormones	[9] [10].	The	mitochondrion	is	evidently	a	vital	constituent	of	our	cells	and	maintenance	of	healthy	mitochondria	thereby	of	utmost	importance.		The	mitochondrion	exhibits	a	complex	organization,	shown	to	be	vital	for	its	proper	functioning.	It	consists	of	an	inner	and	an	outer	membrane,	which	collaborate	in	carrying	out	essential	functions	such	as	protein	import	[11].	As	it	carries	out	oxidative	phosphorylation,	it	also	comprises	all	of	the	sub	complexes	of	the	respiratory	complex	as	well	as	its	own	DNA,	simply	called	mitochondrial	DNA	or	mtDNA.	The	inner	membrane	exhibits	a	very	distinct	architecture,	which	has	been	shown	to	be	important	for	properly	functioning	mitochondria.	It	is	divided	into	three	subsections;	the	inner	boundary	membrane	(IBM),	the	cristae	junctions	(CJs)	and	the	cristae.	As	can	be	seen	in	figure	1	below,	the	cristae	are	invaginations	that	greatly	increase	the	surface	area	of	the	inner	membrane.		They	have	been	shown	to	be	highly	enriched	in	sub	complexes	of	the	respiratory	complex,	and	mutations	affecting	the	cristae	have	been	shown	to	lead	to	grave	impairment	of	the	respiratory	activity	of	the	cell	[12].	The	inner	membrane	is	bent	to	form	cristae	at	the	cristae	junctions.	The	contact	sites,	abbreviated	CS	in	the	figure,	are	sections	of	the	inner	boundary	membrane	enriched	in	proteins	responsible	for	vital	functions	such	as	protein	import	[13].	The	mitochondrial	DNA	is	located	in	close	proximity	to	these	contact	sites	in	the	mitochondrial	matrix	[6].		
	
Figure	1.	Cristae	and	the	MICOS	complex.		Cristae	are	invaginations	that	greatly	increase	the	surface	area	of	the	inner	membrane.	The	MICOS	complex	(previously	known	as	MINOS	complex)	is	located	on	each	side	of	the	cristae [14].	
MtDNA	Mitochondrial	DNA	of	S.	cerevisiae	is	roughly	85.8	kB	in	size,	with	usually	between	20-100	copies	per	yeast	cell	[15].	It	has	been	seen	to	localize	to	punctate	structures	uniformly	distributed	along	the	mitochondria	called	mtDNA	nucleoids.	MtDNA	contains	sequences	encoding	vital	subunits	of	the	respiratory	complex,	thereby	playing	an	important	part	in	the	formation	of	a	functional	respiratory	complex	(figure	2)	[16].	The	mtDNA	however	only	encodes	only	37	of	the	roughly	3000	genes	needed	for	constructing	a	mitochondrion	[17].			
	
Figure	2.	MtDNA	of	Saccharomyces	Cerevisiae	[18].		Yeast	cells	have	the	ability	survive	without	mtDNA	through	anaerobic	respiration,	where	the	energy	provision	is	shifted	from	oxidative	phosphorylation	to	production	of	ATP	through	glycolysis	[19].	Several	severe	diseases	and	conditions	have	been	coupled	to	changes	in	mtDNA.	However,	due	to	factors	such	as	the	presence	of	numerous	mtDNA	copies	in	each	cell,	a	different	inheritance	mechanism	compared	to	nuclear	DNA	(mtDNA	is	maternally	inherited)	and	a	belief	that	mtDNA	disease	rarely	occurs,	knowledge	within	the	field	has	up	until	recent	years	been	relatively	limited	[20].	Later	years	increased	research	has	however	lead	to	identification	of	an	increasing	number	of	diseases	coupled	to	changes	in	mtDNA,	and	mitochondrial	functional	decline	in	elderly	has	for	example	been	related	to	age-related	diabetes	type	II	[21]	as	well	as	observations	of	increased	somatic	mtDNA	mutations	in	human	primary	cancers	[22].	Furthermore,	the	mere	presence	of	mtDNA	has	been	shown	to	play	an	important	role	in	a	cell	cycle	checkpoint	called	the	mtDNA	inheritance	checkpoint	[4].	
Cell	cycle	checkpoints	The	most	thoroughly	studied	checkpoints	have	been	shown	to	act	by	three	main	mediators:	a	sensor,	which	detects	a	certain	unwanted	alteration	in	a	cell,	a	signal	transduction	pathway	and	an	effector,	which	can	halt	the	progress	of	the	cell	cycle,	hopefully	repair	the	damage	and	if	not	so	trigger	cell	death [23].	Cell	cycle	checkpoints	are	best	characterized	in	mammalian	cells.	As	an	example,	cell	cycle	arrest	in	the	G1/S	checkpoint	is	initiated	by	the	inactivation	of	Cdc25A.	The	mentioned	protein	works	by	cancelling	the	inhibitory	phosphorylation	of	CDK2	(cyclin-dependent	kinase	2),	which	activity	is	required	for	cell	cycle	progression	[24].	The	arrest	is	subsequently	prolonged	through	the	induction	of	p53	activity	[25].	p53	promotes	transcription	of	several	genes,	such	as	a	cyclin-dependent	kinase	inhibitor	(CKI)	called	p21,	which	stages	cyclin-dependent	kinase	(CDK)	inhibition	and	thereby	cell	cycle	arrest	[26].			Previous	studies	in	the	Pon	laboratory	revealed	a	checkpoint	that	responds	to	loss	of	mtDNA.	They	showed	that	deletion	of	mtDNA	resulted	in	inhibition	of	cell	cycle	progression	from	G1	to	S	phase	in	the	cell	division	cycle.	To	verify	that	the	result	was	not	due	to	loss	of	genes	encoded	by	the	mtDNA,	experiments	were	conducted	where	native	mtDNA	was	replaced	with	non-coding	DNA,	which	showed	cell	cycle	progression	[4].	This	implicates	that	the	mere	presence	of	mtDNA	plays	an	important	role	in	the	checkpoint.	Furthermore,	it	was	observed	that	Rad53p,	the	yeast	homologue	to	the	mammalian	protein	kinase	Chk2	involved	in	the	DNA	damage	checkpoint,	plays	a	regulatory	role	in	the	mtDNA	inheritance	checkpoint	[4].	The	mechanism	of	signal	transduction	from	the	mtDNA	nucleoids	to	the	nucleus	however	remained	unclear,	and	cells	lacking	mtDNA	(called	Rho0	cells)	were	thereby	vital	for	gaining	further	understanding	of	the	checkpoint.		Knowledge	about	the	sensor	of	the	mtDNA	inheritance	checkpoint	was	scarce,	but	studies	conducted	by	Pallavi	Srivastava	of	the	Pon	lab	showed	that	deletion	of	a	member	of	the	MICOS	complex	called	MicF	led	Rho0	cells	to	bypass	the	checkpoint	(Unpublished	data).	In	other	words,	due	to	the	deletion	of	this	MICOS	component	they	progressed	in	the	cell	cycle	in	spite	of	their	lack	of	mtDNA.	This	discovery	led	to	further	interest	about	the	functions	of	the	rest	of	the	MICOS	complex	and	their	possible	involvement	in	the	checkpoint,	and	that	is	why	the	MICOS	complex	has	been	in	focus	in	this	project.	
The	MICOS	complex	The	MICOS	(mitochondrial	contact	site	and	cristae	organizing	system)	complex	is	responsible	for	the	organization	of	cristae	and	the	inner	mitochondrial	membrane	
[27].	As	was	shown	previously,	the	inner	mitochondrial	membrane	comprises	a	highly	elaborate	architecture,	for	which	the	MICOS	complex	plays	an	important	role	[28]	[29].	It	has	been	shown	to	be	of	importance	for	formation	of	cristae	junctions,	which	in	turn	is	critical	for	mitochondrial	respiratory	activity,	for	formation	of	contact	sites	between	mitochondrial	outer	and	inner	membranes	and	for	maintenance	of	mtDNA	[30] [31].	The	mtDNA	is	located	in	close	proximity	to	the	contact	sites	in	the	mitochondrial	matrix.		
The	MICOS	complex	consists	of	six,	or	possibly	seven	members	as	a	novel	protein	and	a	possible	new	member	has	recently	have	discovered.	These	are	MicA,	MicB,	MicC,	MicD,	MicE,	MicF	and	the	novel	protein,	which	so	far	goes	under	the	name	of	F2.	Recent	reports	have	also	suggested	that	Cox17	in	yeast	and	Qil1	in	humans	also	interact	with	the	MICOS	complex	[32] [33].	It	has	recently	been	shown	that	the	members	of	the	MICOS	complex	are	further	divided	into	two	sub	complexes;	one	comprising	MicA,	MicB	and	MicE	and	the	other	MicF	and	MicC	[7].	Out	of	the	two	sub	complexes	it	has	furthermore	been	suggested	that	MicA	and	MicF	functions	as	key	players	in	the	assembly	and	functions	of	their	respective	sub	complex	[27] [29] [34].		The	members	of	the	complex	are	further	described	below,	where	they	are	divided	according	to	the	mentioned	sub	complexes.	
MicF	The	most	studied	protein	and	a	crucial	component	of	the	MICOS	complex	is	MicF.	As	mentioned,	studies	carried	out	by	Pallavi	Srivastava	of	the	Pon	lab	showed	that	MicF-deletions	in	Rho0	cells	led	to	bypass	of	the	mtDNA	inheritance	checkpoint,	indicating	that	the	protein	might	be	involved	in	the	signal	transduction	from	mtDNA	necessary	to	initiate	cell	cycle	arrest	(Unpublished	data).			This	suggestion	is	strengthened	by	observations	that	MicF	interacts	both	with	the	SAM	and	the	TOM	complex	of	the	outer	membrane	as	well	as	with	mtDNA	[27]	[34] 
[35],	opening	up	the	possibility	that	MicF	is	responsible	for	the	transfer	of	signal	from	mtDNA	nucleoids	to	the	outer	mitochondrial	membrane	in	the	checkpoint.			The	Nunnari	lab	also	showed	in	a	MICOS	deletion	strain,	in	which	every	component	of	the	MICOS	complex	was	knocked	out	except	for	MicF,	that	it	has	the	ability	to	independently	localize	to	substructures	of	the	inner	mitochondrial	membrane	and	thereby	probably	to	self-assemble	[7].	Looking	closer	into	these	localizations,	it	was	seen	that	it	was	in	close	proximity	to	the	respiratory	complexes	and	cristae	markers	Qcr2	and	Atp2,	suggesting	that	MicF	furthermore	marks	cristae	junctions	[7].		
MicC	MicF	is	accompanied	by	MicC	in	one	of	the	sub	complexes,	and	the	former	has	been	shown	to	be	required	for	MicC	stability. Even	though	MicC	is	considered	part	of	the	MicF	sub	complex,	it	was	discovered	that	MicC	has	a	functional	relationship	to	both	of	the	MICOS	sub	complexes;	MicC	has	been	shown	to	disperse	MicF	foci	in	the	MICOS	knockout	strain,	as	only	20%	of	the	cells	displayed	MicF-EGFP	foci	with	MicC	present	as	compared	to	80%	when	only	MicC	was	absent.	The	absence	of	MicC	also	specifically	resulted	in	the	formation	of	MicE	focal	assemblies	in	cells. It	has	thereby	been	suggested	that	MicC,	the	only	member	of	the	MICOS	complex	which	is	localized	to	the	inter	membrane	space	between	the	two	mitochondrial	membranes,	operates	as	an	assembly	regulator	of	the	sub	complexes.	This	hypothesis	was	evaluated	by	mass	spectrometry	of	MicF	purifications	from	both	the	mentioned	MICOS	deletion	strain	and	wild	type.	MicF	lost	almost	all	of	its	interactions	with	the	rest	of	the	MICOS	complex	in	the	absence	of	MicC,	further	strengthening	the	suggestion	that	it	works	as	an	assembly	regulator	of	the	sub	complexes	[7]. 
	Studies	conducted	in	mammalian	cells	showed	that	the	same	scenario	could	be	true	there,	as	knockdown	of	MicC	resulted	in	a	highly	reduced	amount	of	an	intact	MICOS	complex.	Its	knockdown	was	also	seen	to	lead	to	highly	disrupted	formation	of	cristae	
[36].	
MicA	MicA,	together	with	MicF	has	been	found	to	be	conserved	within	a	large	amount	of	eukaryotes,	while	the	conservation	of	most	other	MICOS	components	is	restricted	to	the	opisthokonts	[37].	Deletion	of	MicA	has	furthermore	been	shown	to	lead	to	severe	alterations	of	mitochondrial	morphology	and	is	believed	to	be	a	key	player	within	the	MICOS	complex,	together	with	MicF	[29].		MicA	was	shown	to	be	responsible	for	altering	the	inner	mitochondrial	membrane	by	bending	the	cristae	into	their	characteristic	hairpin	loop	structures	at	the	cristae	junctions	by	homo-oligomerizing.	Two	glycine-rich	motifs	of	the	protein	enable	this	homo-oligomerization [38].	These	findings	were	confirmed	by	another	research	team,	which	had	similar	observations	[39].	They	also	found	that	overexpression	of	MicA	led	to	highly	elongated	and	disrupted	cristae.	The	only	other	MICOS	component	that	showed	cristae	alterations	as	a	consequence	of	overexpression	was	MicF,	but	this	overexpression	showed	a	different	cristae	ultrastructure	[39].	
MicE	MicE	has	been	shown	to	be	dependent	on	MicA	for	stability,	as	its	steady-state	levels	were	reduced	by	~80%	micA∆	cells	[29].		Similar	experiments	to	those	carried	out	to	determine	the	localization	of	MicF	in	the	MICOS	deletion	strain	have	been	carried	out	to	determine	the	localization	of	the	MicA/MicE/MicB	sub	complex	in	a	micF∆	strain.	The	results	showed	that	this	sub	complex	seems	to	have	the	ability	to	localize	to	mark	cristae	junctions,	independent	of	MicF	[7].		
MicB	MicB	has	been	shown	to	function	in	supporting	the	formation	and	stability	of	its	sub	complex	[7].	It	is	however	worth	to	note	that	MicB	is	the	only	established	member	of	the	MICOS	complex	that	does	not	have	a	human	homologue	[29]. 
MicD	MicD	is	a	relatively	obscure	protein	which	has	not	been	focused	on	a	lot,	possibly	because	it	is	paralogous	to	MicE.	Recent	studies	however	shed	some	light	on	the	human	form	of	the	protein	by	showing	that	MicD	interacts	with	MicA,	MicE	and	MicF.	They	also	saw	that	MicD	is	antagonistically	regulated	by	MICE	and	coregulated	with	MicA.	This	possibly	suggests	that	these	two	paralogue	proteins	have	partially	overlapping	or	redundant	functions	[40].	
F2	F2	is	a	novel	protein	discovered	in	the	Pon	laboratory,	which	was	indicated	by	genome-wide	screens	that	it	has	the	capacity	to	interact	with	MicF.	Pallavi	Srivastava	from	the	Pon	lab	found	that	the	gene	encoding	F2	is	up-regulated	in	yeast	that	exhibit	tight	mtDNA	checkpoint	control.	She	also	found	that	it	localizes	to	mitochondria	and	
that	rho0	cells	bearing	deletion	in	F2	bypass	the	mtDNA	inheritance	checkpoint	(Unpublished	data).	This	raised	the	interesting	possibility	that	F2	is	a	possible	component	of	the	MICOS	complex	that	contributes	to	the	mtDNA	inheritance	checkpoint	control.	
3.	Materials	and	Methods	
Yeast	Growth	Conditions	
S.	Cerevisiae	of	the	genetic	background	BY4741	(MATa	his3Δ1	leu2Δ0	met15Δ0	
ura3Δ0)	from	Open	Biosystems	(Huntsville,	AL)	was	used	for	construction	of	all	recombinant	strains	used	in	the	experiments	(Supplemental	table	1).	Synthetic	Complete	(SC)	medium	was	used	unless	otherwise	indicated.	Cells	were	grown	in	5	mL	of	medium	in	50	mL	Falcon	conical	bottom	tubes	in	a	shaking	incubator	at	30°C.	Cells	were	grown	to	mid-log	phase	(OD600	=	0.1	-	0.3)	prior	to	all	experiments.	
Strain	Construction	and	deletion	of	mtDNA	
S.	cerevisiae	strains	used	in	this	study	are	summarized	in	Supplemental	Table	1.	All	yeast	strains	were	created	in	the	BY4741	wild-type	background	by	homologous	recombination	according	to	a	standard	lithium	acetate	protocol	(R.	D.	Gietz,	R.	H.	Schiestl,	A.	R.	Willems,	and	R.	A.	Woods,	"Studies	on	the	transformation	of	intact	yeast	cells	by	the	LiAc/SS-DNA/PEG	procedure,"	Yeast,	vol.	11,	pp.	355-60,	Apr	15	1995)	
[41].	Deletion	strains	were	created	by	disrupting	genomic	locus	of	MICOS	genes	in	WT	and	cells	expressing	Tom70p-GFP	and	Cit1p-mcherry	by	transformation	with	a	PCR-amplified	cassette	from	pFA6a-KanMX6	containing	the	kanMX	selectable	marker	or	PCR-amplified	sequence	containing	LEU2	derived	from	the	pOM	cassette	system.	
MICOS	genes	were	tagged	at	its	C-terminus	with	GFP	by	transformation	with	a	PCR-amplified	GFP	tagging	cassette	from	the	pFA6a-GFP	system	(Addgene,	Cambridge,	MA)	containing	HIS3	and	40–base	pair	homology	to	the	endogenous	locus.	Disruption	of	a	gene	was	verified	using	PCR	amplification		Rho0	derivatives	were	generated	from	wild	type	by	two	consecutive	1-d	treatments	of	25	μM	EtBr	(Goldring	et	al.,	1971)	[42].	Rho0	cells	were	confirmed	by	lack	of	growth	on	plates	containing	a	non	fermentable	carbon	source	and	absence	of	mtDNA	with	DAPI	staining.		
Microscopy	Images	were	collected	with	a	microscope	(Axioskop	2;	Carl	Zeiss)	equipped	with	a	100×/1.4	Plan-Apochromat	objective	(Zeiss,	Thornwood,	NY)	and	a	cooled	charge-coupled	device	camera	(ORCA-1;	Hamamatsu	Photonics)	at	25°C.	For	visualization	of	GFP,	mCherry,	and	DAPI,	fluorophores	were	excited	by	a	mercury	arc	lamp	and	imaged	through	a	motorized	filter	wheel	using	the	following	filters:	GFP	(excitation	482/28,	emission	525/50),	mCherry	(excitation	545/25,	emission	632/60),	and	DAPI	(excitation	402/15,	emission	455/50).	Hardware	was	controlled	by	Nikon	Elements	software.	Z	stacks	were	obtained	in	13	steps	at	0.5	µm	intervals,	and	images	were	finally	deconvolved	using	a	constrained	iterative	restoration	algorithm	in	Volocity	5.5	(PerkinElmer).		
Growth	rate	analysis	All	strains	of	both	Rho+	and	Rho0	were	grown	to	mid-log	phase	and	transferred	to	a	sterile	96-well	plate.	A	growth	curve	analysis	assay	was	run	for	all	of	the	strains	using	a	Tecan	Infinite®	200	NanoQuant	(Tecan	US,	Morrisville,	NC)	measuring	the	optical	density	at	600nm	every	20	minutes	for	72	hours.	The	plate	reader	was	operated	using	Magellan	software.	
Flow	cytometric	cell	cycle	analysis	Cell	cycle	analysis	was	conducted	in	brief	through	the	following	procedure:	Cells	were	synchronized	by	adding	𝛼-factor	at	G1	stage.	Cells	then	were	collected	at	0,	20,	40,	60,	80,	100,	120,	150	and	180	minutes,	fixed	with	ethanol	and	subsequently	stained	with	propidium	iodide	and	analyzed	in	a	fluorescence-activated	cell	analyzer	(LSR	II;	BD).	The	amount	of	cells	in	every	stage	of	the	cell	cycle	was	finally	determined	using	the	FlowJo	software	(Tree	Star).	Fold	change	was	determined	by	comparing	the	amount	of	cells	having	progressed	from	G1	from	time	point	zero.	
4.	Hypothesis	MtDNA	resides	within	the	mitochondrial	matrix	and	is	tightly	associated	with	mitochondrial	membranes	at	sites	of	close	contact	between	the	mitochondrial	outer	and	inner	membranes.	However,	the	checkpoint	machinery	that	inhibits	cell	cycle	progression	in	response	to	loss	of	mtDNA	resides	within	the	nucleus.			One	fundamental	question	is	how	information	regarding	mtDNA	content	can	be	transmitted	from	the	mitochondrial	matrix	to	the	cytosol	and	ultimately	to	the	nucleus.	We	propose	that	this	signal	is	transmitted	across	contact	sites	between	outer	and	inner	membranes.	Indeed,	our	finding	that	deletion	of	MICF,	which	results	in	loss	of	contact	sites,	bypasses	the	mtDNA	inheritance	checkpoint.	Based	on	these	findings,	we	hypothesized	that	one	or	more	MICOS	members	are	involved	in	the	signal	transduction	from	mtDNA	nucleoids	in	the	mtDNA	inheritance	checkpoint	in	addition	to	MicF.		Based	on	the	findings	that	the	novel	protein	F2	interacts	with	MicF	and	that	f2∆	Rho0	cells	also	bypass	the	mtDNA	inheritance	checkpoint,	we	also	hypothesized	that	F2	additionally	interacts	with	other	MICOS	components.		 	
5.	Results	and	discussion	
Deletion	of	MICOS	proteins	affects	mitochondrial	morphology	To	assess	the	effects	of	deletion	of	the	MICOS	components	on	mitochondrial	morphology,	they	were	deleted	in	a	yeast	strain	expressing	Tom70-GFP	and	Cit1-mcherry.	Tom70p	is	an	outer	membrane	protein	and	Cit1p	is	localized	to	the	mitochondrial	matrix,	which	allowed	us	to	efficiently	examine	the	effects	through	fluorescence	microscopy.		We	found	that,	in	accordance	to	what	has	been	reported	earlier,	all	of	the	deletion	strains	show	high	amounts	of	lamellar	mitochondrial	morphology	compared	to	the	reticular	mitochondria	seen	in	wild	type.	According	to	expectations,	we	saw	that	the	suggested	key	players	MicA	and	MicF	knockouts	exhibited	very	high	levels	of	lamellar	mitochondria	(80%	in	micA∆	and	85%	in	micF∆)	[29].			
micC∆	and	micE∆	cells	however	surprisingly	showed	even	higher	degrees	of	lamellar	mitochondria	(93%	in	both	micC∆	and	micE∆)	than	previously	reported	(75%	in	both	
micC∆	and	micE∆)	[29].			The	relatively	low	amounts	of	lamellar	mitochondria	seen	in	micB∆and	micD∆	(63%	and	64%	respectively)	were	however	not	a	surprise,	given	that	they	are	suggested	to	play	peripheral	roles	in	the	complex.	The	exhibited	amounts	are	similar	to	observations	made	in	previous	reports,	but	slightly	higher	amounts	of	lamellar	mitochondria	were	found	in	micB∆	cells	(30%)	[29].			Our	deletion	strains	exhibited	higher	amounts	of	lamellar	mitochondria	than	reported	earlier.	This	is	because	of	two	reasons:	First,	we	used	only	fluorescence	microscopy	to	examine	the	defect	in	mitochondrial	morphology	while	Hoppins	et	al.,	2011	[29]	have	used	Electron	microscopy	to	study	discrepancies	in	mitochondrial	architecture.	Second,	we	have	quantified	a	relatively	small	number	of	cells	(n=20)	for	these	experiments.	Imaging	more	cells	(n>100)	will	provide	more	accurate	account	of	effect	of	MICOS	deletion.	Nonetheless,	our	results	suggest	that	all	of	the	members	of	the	MICOS	complex	play	important	roles	in	maintaining	the	architecture	of	mitochondria.		
	 	
Figure	3.	Deletion	of	MICOS	proteins	affects	mitochondrial	morphology.	Representative	images	of	matrix	targeted	mCherry	and	outer	membrane	targeted	GFP	wild	type	and	indicated	deletion	strains.			 	
MICOS	mutants	exhibit	altered	mtDNA	morphology	and	distribution	As	mentioned	in	the	introduction,	mtDNA	is	normally	distributed	in	punctate	structures	along	the	inner	mitochondrial	membrane.	The	MICOS	complex	has	been	shown	to	be	vital	for	the	maintenance	of	mtDNA,	as	certain	MICOS	mutants	have	been	shown	to	exhibit	aggregated	nucleoids	of	decreased	number	and	increased	size	[6].	Again,	most	studies	have	focused	on	MicF,	which	has	been	shown	to	be	vital	for	mtDNA	maintenance.	Its	role	in	mtDNA	maintenance	is	due	to	what	was	observed	in	a	recent	study,	that	MicF	plays	a	part	in	the	architecture	of	the	mtDNA	D-loop	[35].	MicA	has	also	been	shown	to	be	important	for	mtDNA	maintenance,	while	micB∆,	micC∆,	
micD∆	and	micE∆	showed	no	effect	on	mtDNA [6].		MICOS	deletion	strains	were	stained	with	DAPI	for	15	minutes,	which	was	enough	time	to	stain	the	mitochondrial	DNA	but	not	to	penetrate	the	nucleus	and	stain	the	nuclear	DNA.	We	found	that	MicA	and	MicF	seem	to	be	crucial	for	mtDNA	maintenance,	since	highly	aggregated	mtDNA	nucleoids	were	observed	in	the	cells	in	micA	and	micF	knockouts	(90%	in	micA∆	and	100%	in	micF∆).	This	is	in	accordance	with	previous	studies	[6].		In	micE∆	we	saw	ambiguous	results,	as	50%	of	the	mtDNA	nucleoids	were	overly	aggregated	in	this	knockout.	The	remaining	MICOS	protein	knockouts	showed	little	or	no	effects	on	the	mtDNA	nucleoids	compared	to	wild	type	(10%	in	micB∆	and	micD∆	and	0%	in	micC∆).	This	was	no	surprise	in	the	case	of	micC∆,	since	it	is	the	only	MICOS	protein	which	is	solely	located	to	the	inter	membrane	space,	whereas	all	the	other	members	of	the	complex	exhibit	at	least	segments	in	both	the	inter	membrane	space	and	the	inner	membrane	[39].	The	relatively	high	amount	of	overly	aggregated	mtDNA	seen	in	micE∆	was	unexpected	and	in	contrast	to	previous	studies,	where	none	of	the	MICOS	protein	knockouts	except	MicA	and	MicF	were	shown	to	have	any	effect	on	mtDNA	maintenance	[6].	This	is	possibly	due	to	the	time	sensitivity	of	DAPI	staining	in	this	case	leading	to	unexpected	results.			In	summary,	these	results	further	strengthens	earlier	research	and	the	suggestion	that	MicA	and	MicF	are	the	key	players	of	the	MICOS	complex,	as	they	are	not	only	very	important	for	maintenance	of	the	inner	membrane	architecture	but	also	for	maintenance	of	mtDNA.		 	
		
	
Figure	4.	MICOS	mutants	exhibit	altered	mtDNA	morphology	and	distribution.	DAPI	staining	revealed	that	micA∆	and	micF∆	exhibit	high	amount	of	overly	aggregated	mtDNA.	Representative	images	are	shown	for	wild	type	and	the	indicated	deletion	strains.	Arrows	point	to	examples	of	aggregated	mtDNA	nucleoids.	
micF∆	and	micA∆	Rho0s	bypass	the	mtDNA	inheritance	checkpoint	Flow	cytometric	cell	cycle	analysis	had	not	been	carried	out	in	MICOS	mutants	previous	to	these	trials,	except	for	the	micF∆	trial	carried	out	by	Pallavi	Srivastava,	and	they	were	the	core	of	this	project	since	the	results	give	good	indications	whether	they	play	important	roles	in	the	mtDNA	inheritance	checkpoint.			The	analysis	was	conducted	by	synchronizing	the	cells	at	G1	stage,	followed	by	releasing	them	into	the	cell	cycle	and	subsequently	collecting	the	cells	at	different	time	points	and	fixing	them	with	ethanol.	The	cells	were	then	stained	with	DNA	binding	dye,	propidium	iodide,	and	DNA	content	was	quantified	by	flow	cytometery.	We	have	also	examined	the	growth	rate	of	wild	type	and	all	MICOS	deletion	strains	with	(rho+)	or	without	mtDNA	(rho0).	The	growth	curve	analysis	was	carried	out	by	growing	cells	in	rich	growth	medium	(YPD)	and	measuring	the	optical	density	every	20	minuted	for	72	hours.		Growth	and	cell	cycle	progression	of	wild	type	was	analysed	and	used	as	a	reference	that	MICOS	mutants	could	be	compared	to.	As	expected,	wild	type	Rho+	exhibited	a	steady	growth	rate	and	cell	cycle	progression	and	the	results	were	thereby	used	as	a	reference	in	each	MICOS	deletion	analysis.		We	found	that	micA∆	Rho0	progressed	in	the	cell	cycle	and	thereby	bypassed	the	mtDNA	inheritance	checkpoint.	The	growth	curve	analysis	showed	that	micA∆	Rho0		cells	exhibit	a	growth	rate	similar	to	the	rho+	cells,	which	further	strengthened	the	finding	that	micA∆	Rho0	cells	do	not	arrest	at	G1/S	stage	in	the	cell	cycle	(Figure	5).	These	results	are	in	line	with	the	other	experiments,	in	which	MicA	has	also	proven	to	be	a	key	player,	and	it	suggests	that	MicA	plays	an	important	role	also	in	the	checkpoint.		
	
	
Figure	5.	micA∆	bypasses	the	mtDNA	inheritance	checkpoint.	
(A)	Cell	cycle	analysis	showing	progress	for	micA∆	in	the	cell	cycle.	
(B)	Growth	curve	for	micA∆,	showing	steady	growth	close	to	that	of	wild	type	Rho+.	
	
micB∆	Rho0	does	not	seem	to	bypass	the	mtDNA	inheritance	checkpoint.	micB∆	Rho+		and	micB∆	Rho0	progress	in	the	cell	cycle	similarly	to	the	wild	type	Rho+	and	wild	type	Rho0,	respectively.	The	growth	rate	of	the	micB∆	cells	is	similar	to	that	of	wild	type	(Figure	6).		
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Figure	6.	micB∆	does	not	bypass	the	mtDNA	inheritance	checkpoint.	
(A)	Cell	cycle	analysis	showing	cell	cycle	arrest	for	micB∆	Rho0	in	the	cell	cycle.	
(B)	Growth	curve	for	micB∆,	showing	limited	growth	close	to	that	of	wild	type	Rho0.			
micC∆	Rho0	neither	bypassed	the	mtDNA	inheritane	checkpoint.	The	growth	curve	strengthened	this	result,	as	this	strain	was	seen	to	be	highly	growth	deficient	(Figure	7).		 	
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Figure	7.	micC∆	does	not	bypass	the	mtDNA	inheritance	checkpoint.	
(A)	Cell	cycle	analysis	showing	cell	cycle	arrest	for	micC∆	Rho0	in	the	cell	cycle.	
(B)	Growth	curve	for	micC∆,	showing	limited	growth	close	to	that	of	wild	type	Rho0.	In	micD∆	strains,	both	Rho+	and	Rho0	were	found	to	be	arrested	at	G1/S	stage.	This	is	a	very	surprising	result	as	micD∆	Rho+	cells	do	not	show	significant	defects/loss	of	mtDNA	organization.	Growth	rate	of	micD∆	Rho0	is	however	as	expected	significantly	lower	than	that	of	micD∆	Rho+	.	Further	investigation	is	required	to	completely	understand	the	role	of	micD	in	cell	cycle	progression.						
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Figure	8.	micD∆	does	not	bypass	the	mtDNA	inheritance	checkpoint.	
(A)	Cell	cycle	analysis	showing	cell	cycle	arrest	for	both	micD∆	Rho0	and	micD∆	Rho+	in	the	cell	cycle.	
(B)	Growth	curve	for	micD∆,	showing	slightly	limited	growth	of	mic26∆	Rho0.	
micE∆	Rho+	and	micE∆	Rho0	cells	have	progressed	in	the	cell	cycle	but	at	a	lower	rate	that	of	wild	type	Rho+	cells.	micE∆	Rho0	cells	however	displayed	defect	in	growth	rate	in	comparison	to	micE∆	Rho+	cells.	This	partial	bypass	observed	in	the	micE∆	cells	cannot	be	explained	from	our	current	understanding	of	this	matter	and	requires	further	investigation	(Figure	9).			 	
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Figure	9.	micE∆	does	bypass	the	mtDNA	inheritance	checkpoint.	
(A)	Cell	cycle	analysis	indicating	possible	bypass	of	the	mtDNA	inheritance	checkpoint	for	both	micE∆	Rho0	and	micE∆	Rho+.	
(B)	Growth	curve	for	micE∆,	showing	slightly	limited	growth	of	micE∆	Rho0.	Altogether,	our	results	indicate	that	MicA	in	addition	to	MicF	plays	a	vital	role	in	the	mtDNA	inheritance	checkpoint,	which	has	never	been	shown	before.	Since	the	MicE	Rho0	knockout	also	showed	a	potential	bypass	of	the	checkpoint,	this	protein	should	be	further	studied	to	establish	its	role	in	the	checkpoint.	In	addition,	the	Rho+	knockouts	of	MicD	and	MicE	showed	somewhat	confusing	results,	as	they	did	not	progress	in	the	cell	cycle.	None	of	the	other	MICOS	proteins	are	indicated	to	be	crucial	for	maintaining	a	functional	checkpoint.		 	
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F2	is	not	required	for	MICOS	localization	Previous	studies	by	Pallavi	Srivastava	indicate	that	MicF	is	required	for	normal	localization	of	F2,	as	deletion	of	MICF	results	in	decrease	in	the	amount	of	F2	that	localizes	to	mitochondria.	We	speculate	that	F2	may	be	a	novel	protein	of	the	MICOS	complex,	so	we	decided	to	study	its	possible	interactions	with	other	MICOS	proteins.		To	test	this,	we	decided	to	microscopically	examine	GFP-tagged	MICOS	proteins	in	a	F2	deletion	strain	and	determine	whether	the	MICOS	proteins	localize	to	mitochondria	properly	compared	to	wild	type.		MICOS	proteins	localize	to	punctate	structures	that	co-localize	with	mitochondria.	We	find	that	deletion	of	F2	does	not	have	any	obvious	effect	on	the	localization	or	distribution	of	all	MICOS	proteins	studied	(Figure	11).			
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Figure	10.	F2	is	not	required	for	MICOS	localization.	
(A)	MicA	was	distributed	in	a	similarly	focal-like	pattern	also	in	the	absence	of	F2.	
(B)	No	effects	on	the	distribution	of	MicB	could	be	seen	in	the	absence	of	F2.	
(C)	Neither	the	distribution	of	MicC	was	affected	by	the	F2	deletion	
(D)	No	effects	on	the	distribution	of	MicD	could	be	seen	in	the	F2	deletion	strain.		
(E)	MicE	distribution	was	unaffected	by	the	deletion	of	F2.		
F2	does	not	require	MicD	or	MicE	for	localization	Corresponding	experiments	were	made	for	the	opposite	situation,	i.e.	examination	of	GFP-tagged	F2	in	micD∆	and	micE∆	cells.	F2	was	found	to	localize	to	bright	foci	in	a	pattern	along	the	mitochondria	in	wild	type,	similar	to	what	was	observed	for	the	MICOS	proteins.	Examination	of	F2-GFP	in	the	remaining	MICOS	knockout	strains	did	unfortunately	not	fit	the	time	frame	of	the	project	and	should	be	carried	out	in	order	to	obtain	the	whole	picture.	
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	In	contrast	to	the	earlier	observations	that	F2	requires	MicF	for	localization,	foci	of	F2-GFP	was	not	seen	to	vary	significantly	between	micD∆,	micE∆	and	wild	type	(Figure	12).				
	
	
	
Figure	12.	F2	does	not	require	MicD	or	MicE	for	localization.	No	effects	on	F2	distribution	could	be	seen	in	any	of	the	studied	knockouts.	Altogether	we	found	that	none	of	the	established	MICOS	proteins	localized	differently	compared	to	wild	type	in	the	f2∆	cells.	Neither	did	we	observe	that	F2	localized	differently	in	the	absence	of	MicD	and	MicE.		 	
4.	Conclusions	and	Future	directions	We	have	seen	that	MicA	and	MicF	seem	to	be	the	most	important	constituents	of	the	MICOS	complex,	and	that	they	both	play	vital	roles	in	the	signal	transduction	from	mtDNA	nucleoids	to	the	outside	of	mitochondria.	We	speculate	that	MicF	might	be	either	directly	or	indirectly	responsible	for	mediation	of	the	signal	from	the	mtDNA	nucleoids,	as	it	has	been	seen	that	MicF	physically	interacts	with	both	mtDNA	[35]	and	the	SAM	and	the	TOM	complex	of	the	outer	mitochondrial	membrane	[27] [34].	We	also	speculate	that	MicA,	which	plays	a	vital	role	by	bending	the	inner	membrane	to	form	cristae	by	homo-oligomerizing,	is	responsible	for	maintaining	the	contact	sites	without	which	signal	transduction	would	be	impaired.		
Table	1.	Summary	of	the	results	from	studies	on	mitochondrial	morphology,	mtDNA	aggregation	
and	mtDNA	inheritance	checkpoint	arrest	of	the	MICOS	deletions.	
Strain	 Defects	in	
mitochondrial	
morphology	(%	of	
cells	analyzed)	
Aggregated	mtDNA	
nucleoids	(%	of	cells	
analyzed)	
MtDNA	inheritance	
checkpoint	arrest	
WT	 0	 0	 +	
micA∆	 80	 90	 -	
micB∆	 63	 10	 +	
micC∆	 93	 0	 +	
micD∆	 64	 10	 ?	
micE∆	 93	 50	 ?	
micF∆	 85	 100	 -			Altogether,	we	find	that	all	of	the	members	of	the	MICOS	complex	affect	the	mitochondrial	morphology	but	only	MicA,	MicF	and	possibly	MicE	affect	mtDNA	nucleoid	structure.	Our	data	indicate	that	the	role	of	MICOS	proteins	in	controlling	the	mitochondrial	architecture	might	not	be	important	for	its	ability	for	signal	transduction	from	the	mtDNA.	We	however	observed	a	correlation	between	the	MICOS	proteins	involved	in	mtDNA	nucleoid	morphology	and	bypass	of	the	mtDNA	inheritance	checkpoint.		We	gained	some	insights	on	how	signal	transduction	from	the	mtDNA	nucleoids	to	the	outside	of	the	mitochondria	is	carried	out	in	the	mtDNA	inheritance	checkpoint,	but	how	the	signal	from	the	surface	of	the	mitochondria	through	the	cytosol	to	the	nucleus	is	carried	out	remains	to	be	elucidated.		We	also	obtained	preliminary	evidence	through	live	cell	microscopy	that	F2	interacts	with	and	requires	MicA	for	localization,	in	addition	to	MicF.	Further	research	should	focus	on	determining	the	role	of	MicA	in	F2	localization.	Possible	interactions	with	other	MICOS	complex	proteins	should	also	be	researched	in	order	to	determine	its	role	within	the	complex.		 	
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Supplemental	table	2.	Strains	used	in	the	project.	
Strain	
name	
Parent(s)	 Genotype	
MHY001	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::KANMX 
MHY002	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::KANMX 
MHY003	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::KANMX tom70 GFP::his3Δ1 
cit1mcherry::hygro 
MHY004	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::KANMX tom70 GFP::his3Δ1 
cit1mcherry::hygro 
MHY005	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micEΔ::KANMX tom70 GFP::his3Δ1 
cit1mcherry::hygro 
MHY006	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micCΔ::KANMX 
MHY007	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micCΔ::KANMX 
MHY008	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micCΔ::KANMX tom70 GFP::his3Δ1 
cit1mcherry::hygro 
MHY009	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micEΔ::KANMX 
MHY010	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::KANMX Rho0 
MHY011	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 WT::KANMX Rho0 
MHY012	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micCΔ::KANMX Rho0 
MHY013	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micAΔ::POM13 
MHY014	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micAΔ::POM13 tom70 GFP::his3Δ1 
cit1mcherry::hygro 
MHY015	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micDΔ::KANMX 
MHY016	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micDΔ::KANMX tom70 GFP::his3Δ1 
cit1mcherry::hygro 
MHY017	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micFΔ::POM13 
MHY018	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micCΔ::POM13 Rho0 
MHY019	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micDΔ::KANMX Rho0 
MHY020	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micEΔ::KANMX Rho0 
MHY021	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micFΔ::POM13 Rho0 
MHY022	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micCΔ::KANMX Rho0 
MHY023	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micEΔ::KANMX 
MHY024	 BY4741	  
MHY025	 BY4741	   
MHY026	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicAGFP::HIS 
MHY027	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicAGFP::HIS 
MHY028	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicAGFP::HIS 
MHY029	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicBGFP::HIS 
MHY030	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicBGFP::HIS 
MHY031	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicBGFP::HIS 
MHY032	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicCGFP::HIS 
MHY033	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicCGFP::HIS 
MHY034	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicCGFP::HIS 
MHY035	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicDGFP::HIS 
MHY036	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicDGFP::HIS 
MHY037	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicDGFP::HIS 
MHY038	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicEGFP::HIS 
MHY039	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicEGFP::HIS 
MHY040	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicEGFP::HIS 
MHY041	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicEGFP::HIS 
MHY042	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micAΔ::POM13 fjrp2GFP::HIS 
MHY043	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micAΔ::POM13 fjrp2GFP::HIS 
MHY044	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::POM13 fjrp2GFP::HIS 
MHY045	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::POM13 fjrp2GFP::HIS 
MHY046	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micDΔ::POM13 fjrp2GFP::HIS 
MHY047	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micEΔ::POM13 fjrp2GFP::HIS 
MHY048	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micEΔ::POM13 fjrp2GFP::HIS 
MHY049	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micBΔ::POM13 fjrp2GFP::HIS 
MHY050	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fjrp2Δ::KANMX MicEGFP::HIS 
MHY051	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MicEGFP::HIS 
MHY052	 BY4741	 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 micEΔ::POM13 fjrp2GFP::HIS 	
Supplemental	table	3.	Primers	used	during	the	project	
Purpose	 Plasmid	 Sequence	
Deletion	of	MICA	 pFA6a	 CTACGAGAGGGAATAAACACGGAAAAAGACAAAAT	
ATACCCGGATCCCCGGGTTAATTAA	
Deletion	of	MICA	 pFA6a	 TTTTTTTTTTTGAATATATATAAAGCATCGTCGCTTAA	
GAGAATTCGAGCTCGTTTAAAC	
Deletion	of	MICB	 pFA6a	 CAGACAGTGGACTAAGAACCAGCAGATAACGGAGAG	
AATCCGATCCCCGGGTTAATTAA	
Deletion	of	MICB	 pFA6a	 CATGAGGATGTTCGTTACAGTAGGAGAAATAGAAAGC	
TCGGAATTCGAGCTCGTTTAAAC	
Deletion	of	MICC	 pFA6a	 ACAAAAACAAGGTGGTATATCGACTAATACAGAGTCAATC	
CGGATCCCCGGGTTAATTAA	
Deletion	of	MICC	 pFA6a	 CGAATTCTTTTTGGTCGAGTTTATGTATACTTTTTCTTAT	
GAATTCGAGCTCGTTTAAAC	
Deletion	of	MICD	 pFA6a	 ATACAAAAATAACTACTGTATTTGATATAGCACGGAAACA	
CGGATCCCCGGGTTAATTAA	
Deletion	of	MICD	 pFA6a	 GTATTTATAAGATGAATAAGCGCCAGGTGCTAAACAGAGT	
GAATTCGAGCTCGTTTAAAC	
Deletion	of	MICE	 pFA6a	 AGACAGAAGCAGCACACCATTTACCAATACAGCTTCCAAA	
CGGATCCCCGGGTTAATTAA	
Deletion	of	MICE	 pFA6a	 ATGGACATGATAATGAACAAAAAAAGATATCCGCTTGATA	
GAATTCGAGCTCGTTTAAAC	
PCR	control	for	MICC	 	 TCAATCATCAATTAAATAAT	
PCR	control	for	MICC	 	 TCATGACACCAAGAGAACAA	
PCR	control	for	MICD	 	 GATGATGGATGATGATGAAG	
PCR	control	for	MICD	 	 AAGACTCAAGCATTCAAAAA	
PCR	control	for	MICE	 	 ATTGCAAGCATGCTTTATAC	
PCR	control	for	MICE	 	 AATTAATGTA
CTACAAACG
A	
PCR	control	for	MICB	 	 GGACTTATCGATGATTTCGT	
PCR	control	for	MICB	 	 TTTCAGCTCAGCCAATTCAA	
PCR	control	for	MICA	 	 TGAATATAAGGAGCGGGTAT	
PCR	control	for	MICA	 	 AATTTTCGTTTTCAGATGTG	
Deletion	of	MICA	 Pom	 CTTTGCTACGAGAGGGAATAAACACGGAAAAAGACAAAATATACC	TGCAGGTCGACAACCCTTAAT	
Deletion	of	MICA	 Pom	 TATTATTTTTTTTTTTGAATATATATAAAGCATCGTCGCTTAAGA	GCAGCGTACGGATATCACCTA	
Deletion	of	MICD	 Pom	 AGGATATACAAAAATAACTACTGTATTTGATATAGCACGGAAACA	TGCAGGTCGACAACCCTTAAT	
Deletion	of	MICD	 Pom	 TGTATGTATTTATAAGATGAATAAGCGCCAGGTGCTAAACAGAGT	GCAGCGTACGGATATCACCTA		
